Investment
Features
FeesSafety
Academy
More
Pluang+

Compare News Corporation Class A Common Stock (NWSA) vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Price & Performance

News Corporation Class A Common StockTrade
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)Trade

Price performance (Past 24H)

Key statistics

News Corporation Class A Common Stock vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? News Corporation Class A Common Stock trades at $29.12 (market cap $16.14B), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.68 (market cap $58.74B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 3.6× News Corporation Class A Common Stock's market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays the higher dividend (3.33%). Which is the better fit depends on your goals — on Pluang, investors hold News Corporation Class A Common Stock for 1 Days and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 1 Days on average.

NWSATAK
Market Cap
$16.14B$58.74B
Volume
4,310,6103,110,994
Sector
MediaHealth
52-Week High
$31.19$19.05
52-Week Low
$22.40$13.23
Typical Hold Time
1 Days1 Days
Enterprise Value
$16.96B$86.65B
Dividend Yield
0.69%3.33%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About News Corporation Class A Common Stock

News Corporation operates businesses in news and information services, digital real estate, and book publishing. Its brands include Dow Jones, The Wall Street Journal, HarperCollins, Realtor.com, and realestate.com.au.

Read more on NWSA →

About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.

Read more on TAK →